ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,578Medicare Part D Prescriptions Filled, Including Refills

Rank: 276 out of 2588

$879K Total Retail Price of All Prescriptions

Rank: 121 out of 2588

486 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 8,633 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
METFORMIN HCL 539 432 1 8
CLARITHROMYCIN 344 244 10 2 320
LEVOTHYROXINE SODIUM 306 251 3 2
AMLODIPINE BESYLATE-BENAZEPRIL 281 224 4 76
ALLOPURINOL 228 190 5 33
MIRTAZAPINE 221 157 6 63
SIMVASTATIN 220 175 7 1
PANTOPRAZOLE SODIUM 217 142 8 28
GLIMEPIRIDE 212 169 9 39
TAMSULOSIN HCL 196 184 10 23
PRAVASTATIN SODIUM 168 108 11 16
NEXIUM 163 99 12 41
AMLODIPINE BESYLATE 159 134 13 4
CEFUROXIME 155 117 14 183
ATORVASTATIN CALCIUM 154 116 15 11
PLAVIX 152 135 16 43
METOPROLOL SUCCINATE 149 137 17 12
FUROSEMIDE 148 104 18 5
ALBUTEROL SULFATE 148 86 18 116
ACTOS 145 86 20 105
OMEPRAZOLE 144 142 21 6
ALENDRONATE SODIUM 138 90 22 21
PROMETHAZINE HCL 134 109 R 23 180
METOPROLOL TARTRATE 125 99 24 9
LEVOFLOXACIN 121 87 25 77
CLOPIDOGREL 119 98 26 30
JANUVIA 119 75 26 60
DEXILANT 118 79 28 250
ENALAPRIL MALEATE 117 94 29 31
CARVEDILOL 114 109 30 20
FINASTERIDE 112 106 31 97
ESCITALOPRAM OXALATE 112 71 31 68
ADVAIR DISKUS 101 49 33 48
NYSTATIN-TRIAMCINOLONE 99 80 34 158
CYMBALTA 97 51 35 70
LISINOPRIL 95 63 36 3
DICLOFENAC SODIUM 93 68 37 124
CRESTOR 92 77 38 25
DIOVAN HCT 91 76 39 72
RAMIPRIL 85 80 40 111
TRAZODONE HCL 79 49 41 61
SINGULAIR 78 63 42 94
TRAMADOL HCL 73 55 43 19
DIOVAN 71 59 44 29
IMIPRAMINE HCL 68 54 R 45 429
ISOSORBIDE MONONITRATE ER 68 46 45 49
ACTONEL 67 55 47 184
AVODART 64 55 48 164
PIOGLITAZONE HCL 62 31 R 49 241
TRIAMCINOLONE ACETONIDE 58 38 50 106
PAROXETINE HCL 56 32 51 71
CEPHALEXIN 56 37 51 138
CELEBREX 55 51 53 99
POTASSIUM CHLORIDE 55 41 53 15
CICLOPIROX 54 43 55 503
HYDROXYCHLOROQUINE SULFATE 54 38 55 224
LOSARTAN-HYDROCHLOROTHIAZIDE 54 54 55 66
NYSTATIN 54 29 55 196
CIPROFLOXACIN HCL 54 42 55 82
HYDROCHLOROTHIAZIDE 53 50 60 13
SPIRIVA 52 29 61 56
RANITIDINE HCL 50 29 62 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.